Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Ushio and Columbia University agree to develop Ultraviolet Disinfection Method

Ushio has entered into exclusive license and research agreements for narrowband- spectrum ultraviolet light technology with Columbia University.

The aim is to promote research and development as well as productization of an Ultraviolet Disinfection Method that utilizes UV radiation within a particular wavelength range to, for example, prevent surgical site infection.

Surgical site infection due to in-hospital infection is a serious problem; more than 8,000 patients in the United States alone die from in-hospital infection, accounting for $3bn to $10bn in annual health care costs.

Dr. David Brenner, Director of the Center for Radiological Research at the Columbia University Medical Center, and his team have developed a disinfection system that selectively kills bacteria and viruses without damaging human cells/tissues. The system, which uses a narrowband-spectrum ultraviolet light technology — for example, the ultraviolet light technology of excimer lamps that produce radiation of a particular wavelength range — can disinfect bacteria and viruses such as MRSA, influenza, MERS-CoV, and SERS-CoV as well as viruses including the Ebola virus.

USHIO was the first company in the world to develop and practically apply excimer lamps, and has manufactured and distributed photo-cleaning products for use in the manufacturing processes of semiconductors and liquid crystal displays. The company also has recently started research on usage of excimer lamps for water processing and deodorization, and is now working on to extend the applications of far-ultraviolet light excimer lamps.

With the execution of the agreements with Columbia University, USHIO is now promoting the development of excimer lamps’ new application to prevent microbial infection in a medical setting. Clinical research in the USA, Singapore, Japan and other places around the world will start from the winter of 2015, with the aim of producing a product sometime around the year 2017. Additionally, the company aims to expand into the sanitary and healthcare fields, and create a business around a safe and foolproof system for disinfection using excimer lamps.

Narrowband Spectrum Ultraviolet Light Technology

1. Wavelength

The method uses a range of UV wavelengths, from about 200 nm to 230 nm. For example, KrBr (207 nm) and/or KrCl (222 nm) can be used, which can be created by cutting a wavelength of about 230 nm or more of far-ultraviolet light generated by excimer lamps.

This UV wavelength range, including these specific UV wavelengths, can penetrate and kill bacteria, but at the cellular level they do not reach the nucleus of human cells, and at the tissue level they will not reach the sensitive cells in the skin epidermis or the eye lens. The latest research proves that the method maintains anti-microbial advantages of conventional UV lamps while drastically reducing biological damage in human cells compared with conventional UV lamps.

2. Potential Applications of the Technology
(1) Minimize surgical-site bacterial infections, particularly from drug-resistant bacteria such as MRSA
(2) Minimize airborne and direct-contact infection of viruses, such as H1N1 (bird influenza), SARS-CoV (SARS coronavirus), MERS-CoV (MERS coronavirus), dengue, and Ebola.
(3) Treat infected chronic wounds.
(4) Add an anti-microbial function to devices such as hand dryers.